Drug Interactions between Jadenu Sprinkle and Prolixin
This report displays the potential drug interactions for the following 2 drugs:
- Jadenu Sprinkle (deferasirox)
- Prolixin (fluphenazine)
Interactions between your drugs
No interactions were found between Jadenu Sprinkle and Prolixin. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Jadenu Sprinkle
A total of 599 drugs are known to interact with Jadenu Sprinkle.
- Jadenu sprinkle is used to treat Iron Overload.
Prolixin
A total of 761 drugs are known to interact with Prolixin.
- Prolixin is in the drug class phenothiazine antipsychotics.
- Prolixin is used to treat Psychosis.
Drug and food interactions
deferasirox food
Applies to: Jadenu Sprinkle (deferasirox)
ADJUST DOSING INTERVAL: According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.
MANAGEMENT: To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.
References (1)
- (2005) "Product Information. Exjade (deferasirox)." Novartis Pharmaceuticals
fluPHENAZine food
Applies to: Prolixin (fluphenazine)
GENERALLY AVOID: Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment. Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines. The two drugs probably act on different sites in the brain, although the exact mechanism of the interaction is not known.
MANAGEMENT: Patients should be advised to avoid alcohol during phenothiazine therapy.
References (2)
- Lutz EG (1976) "Neuroleptic-induced akathisia and dystonia triggered by alcohol." JAMA, 236, p. 2422-3
- Freed E (1981) "Alcohol-triggered-neuroleptic-induced tremor, rigidity and dystonia." Med J Aust, 2, p. 44-5
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.